Sign In
Buy CERT
$5.60
-0.0200 (-0.356%)
At Close: Jun 03, 2026
CERTARA, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
06:00pm, Wednesday, 13'th May 2026
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Certara, Inc. (“Certara” or the “Company”) (NASDAQ:CERT). The investigation concerns wh
SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Certara, Inc. (NASDAQ: CERT). The investigation focuses on Certara's execut
Certara, Inc. (CERT) Q1 2026 Earnings Call Transcript
01:00pm, Monday, 11'th May 2026
Certara, Inc. (CERT) Q1 2026 Earnings Call Transcript
Certara Q1 Earnings Call Highlights
10:07am, Monday, 11'th May 2026
Certara NASDAQ: CERT reported first-quarter 2026 revenue of $106.9 million, up 1% from the prior-year period, as stronger software performance offset softer services results and the company outlined a
Certara, Inc. (CERT) Q1 Earnings Miss Estimates
08:46am, Monday, 11'th May 2026
Certara, Inc. (CERT) came out with quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.14 per share a year ago.
Certara Reports First Quarter 2026 Financial Results
06:25am, Monday, 11'th May 2026
Updates 2026 Guidance to reflect completed divestiture of Regulatory Writing and Medical Writing Business Updates 2026 Guidance to reflect completed divestiture of Regulatory Writing and Medical Writi
Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development
08:00am, Thursday, 07'th May 2026
LAVAL, Québec & RADNOR, Pa.--(BUSINESS WIRE)-- #Altasciences--Altasciences, a fully integrated drug development solution company, and Certara (Nasdaq: CERT), a global leader in model-informed drug de
Certara Strategic Business Divestiture Comes At Right Time, Says Analyst
03:23pm, Wednesday, 22'nd Apr 2026
Certara Inc. (NASDAQ:CERT) shares are up 2.34% on Wednesday as the company announced it has entered into a definitive agreement to sell its Regulatory and Medical Writing business.
Veristat to Acquire Certara's Regulatory and Medical Writing Business
07:00am, Wednesday, 22'nd Apr 2026
SOUTHBOROUGH, Mass.--(BUSINESS WIRE)-- #Biotech--Veristat (the “Company”), a science-first full-service CRO and consultancy that advances complex therapies through the drug development lifecycle t
Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat
07:00am, Wednesday, 22'nd Apr 2026
Transaction sharpens focus on Model-Informed Drug Development (MIDD) and Clinical Intelligence Updated 2026 guidance to be provided upon transaction close RADNOR, Pa., April 22, 2026 (GLOBE NEWSWIRE
Certara to Report First Quarter 2026 Financial Results on May 11th, 2026
04:15pm, Thursday, 09'th Apr 2026
RADNOR, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the first q
Certara, Inc. (NASDAQ:CERT) Given Consensus Recommendation of “Hold” by Analysts
04:43am, Friday, 03'rd Apr 2026
Certara, Inc. (NASDAQ: CERT - Get Free Report) has received an average rating of "Hold" from the fourteen analysts that are covering the firm, MarketBeat Ratings reports. One investment analyst has ra
Cerrado Gold Inc. (CERT:CA) Q4 2025 Earnings Call Transcript
04:12pm, Thursday, 02'nd Apr 2026
Cerrado Gold Inc. (CERT:CA) Q4 2025 Earnings Call Transcript
Brown Brothers Harriman & Co. Has $46 Million Holdings in Certara, Inc. $CERT
04:38am, Saturday, 14'th Mar 2026
Brown Brothers Harriman and Co. boosted its holdings in shares of Certara, Inc. (NASDAQ: CERT) by 34.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchan
Certara, Inc. $CERT Shares Sold by 2Xideas AG
03:49am, Saturday, 14'th Mar 2026
2Xideas AG trimmed its holdings in shares of Certara, Inc. (NASDAQ: CERT) by 41.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 184,198 shares of
